PGMN3 Share Price Performance
R$5.89
2.52 (74.78%)
73.2% overvalued intrinsic discount
R$3.40
Fair Value
Price R$5.89
AnalystLowTarget R$3.40
AnalystConsensusTarget R$5.21
AnalystHighTarget R$5.10
Fair ValueR$3.40
Share Pricen/a
Empreendimentos Pague Menos S.A. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
PGMN3 Community Narratives
AN
Fair Value R$3.4 73.2% overvalued intrinsic discount
Brazil Retail Will Falter Amid Digital Competition
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value R$5.21 13.0% overvalued intrinsic discount
Pharmaceutical Retail And Digital Channels Will Expand Market Reach
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value R$5.6 5.2% overvalued intrinsic discount
Brazil's Aging Demographic Will Ignite Digital Pharmacy Expansion
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Pharmaceutical Retail And Digital Channels Will Expand Market Reach
Key Takeaways Expanding pharmacy offerings, urbanization, and robust digital growth are driving sustained revenue increases, market expansion, and higher-value customer engagement. Operational efficiencies and industry trends are boosting earnings, margins, and positioning for greater market share and long-term profitability.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
R$5.21
13.0% overvalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue
12% p.a.
Profit Margin
1.91%
Future PE
19.33x
Price in 2028
R$7.41
Brazil's Aging Demographic Will Ignite Digital Pharmacy Expansion
Key Takeaways Rapid store integration, digital channel growth, and operational leverage position the company for significant revenue and margin expansion, outpacing analyst expectations. Strong chronic care focus, demographic tailwinds, and local market consolidation drive long-term sales growth, top-line diversification, and industry-leading scale advantages.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
R$5.6
5.2% overvalued intrinsic discount
AnalystHighTarget Fair Value
Revenue
19% p.a.
Profit Margin
1.59%
Future PE
20.75x
Price in 2028
R$9.79
Brazil Retail Will Falter Amid Digital Competition
Key Takeaways Growing digital health adoption and demographic shifts threaten store volumes, limiting revenue growth and the effectiveness of physical expansion strategies. Intensified competition and rising regulatory burdens risk squeezing margins, increasing operational costs, and dampening overall profitability.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
R$3.4
73.2% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue
8% p.a.
Profit Margin
1.66%
Future PE
15.94x
Price in 2028
R$7.81
Trending Discussion
Recently Updated Narratives
AN
PGMN3: Future Performance Will Reflect Modestly Improved Profitability And Lower Discount Rate
Fair Value: R$5.21 13.0% overvalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Brazil Retail Will Falter Amid Digital Competition
Fair Value: R$3.4 73.2% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Brazil's Aging Demographic Will Ignite Digital Pharmacy Expansion
Fair Value: R$5.6 5.2% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Empreendimentos Pague Menos S.A. Key Details
About PGMN3
- Founded
- 1981
- Employees
- 27191
- CEO
- WebsiteView website
Empreendimentos Pague Menos S.A. engages in the retail sale of medicines, perfumes, personal hygiene and beauty products in Brazil. The company offers medicines and health care products in the areas of pediatrics, oncology, psychiatry, urology, orthopedics, dermatology, contraception, pediatric endocrinology, assisted reproduction, geriatric, gastrointestinal and hepatic, pain, fever, and inflammation, diabetes, and endocrinology. It also provides personal care and beauty products, including deodorant, intimate care, and oral hygiene, as well as foot, hair, face, and hand care products; dermo-cosmetics; and repellent, diaper, cloth, and food products, as well as other accessories for moms and babies. In addition, the company offers clothing and accessories, supplements, first aid, food and drink, utilities, and others; and cereals, fibers, vitamins and minerals, first aid, and herbal medicines and natural products. It sells its products through retail stores and online. Empreendimentos Pague Menos S.A. was incorporated in 1981 and is headquartered in Fortaleza, Brazil.
